Methods of activating ATIII in situ in a blood product are disclosed, as is the use of such methods and blood products in treating infectious diseases, inflammatory disorders and diseases or conditions that are mediated by thrombin activation.

 
Web www.patentalert.com

< Method of treatment of glutathione deficient mammals

> Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies

> Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
~ 00502